These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1496 related articles for article (PubMed ID: 22406601)

  • 1. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
    Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
    Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio.
    Bhatti I; Peacock O; Lloyd G; Larvin M; Hall RI
    Am J Surg; 2010 Aug; 200(2):197-203. PubMed ID: 20122680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
    La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
    J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
    La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
    Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
    Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
    Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.
    van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ
    Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.
    Richter A; Niedergethmann M; Sturm JW; Lorenz D; Post S; Trede M
    World J Surg; 2003 Mar; 27(3):324-9. PubMed ID: 12607060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Berger AC; Watson JC; Ross EA; Hoffman JP
    Am Surg; 2004 Mar; 70(3):235-40; discussion 240. PubMed ID: 15055847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
    Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
    Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection.
    Shirai Y; Shiba H; Sakamoto T; Horiuchi T; Haruki K; Fujiwara Y; Futagawa Y; Ohashi T; Yanaga K
    Surgery; 2015 Aug; 158(2):360-5. PubMed ID: 26032829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
    Benassai G; Mastrorilli M; Mosella F; Mosella G
    J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
    Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
    Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of staging node-negative pancreas cancer: a potential quality measure.
    Tomlinson JS; Jain S; Bentrem DJ; Sekeris EG; Maggard MA; Hines OJ; Reber HA; Ko CY
    Arch Surg; 2007 Aug; 142(8):767-723; discussion 773-4. PubMed ID: 17709731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favourable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region.
    Jarufe NP; Coldham C; Mayer AD; Mirza DF; Buckels JA; Bramhall SR
    Dig Surg; 2004; 21(3):202-9. PubMed ID: 15218236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
    Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors affecting survival after pancreaticoduodenectomy for pancreatic adenocarcinoma (single center experience).
    El Nakeeb A; El Shobary M; El Dosoky M; Nabeh A; El Sorogy M; El Eneen AA; abu Zeid M; Elwahab MA
    Hepatogastroenterology; 2014; 61(133):1426-38. PubMed ID: 25436321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Gr├╝tzmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
    Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
    Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 75.